Clinical Study of the Results of Sac Prefilling Performed to Prevent Type II Endoleaks After Endovascular Abdominal Aortic Aneurysm Repair

Abstract

Objectives:

This study investigated the effectiveness and safety of sac prefilling (SP) with fibrin glue and/or a coil to prevent type II endoleaks (T2ELs) after endovascular aneurysm repair. The main outcome measure was prevalence of incidence of T2ELs.

Methods:

First, this is a retrospective observational study on patients treated in our institution. Patients who underwent endovascular aneurysm repair between January 2017 and July 2022 were included and divided into the endovascular aneurysm repair and endovascular aneurysm repair with SP groups. Additionally, all patients were divided into high-risk (HR) and low-risk (LR) groups based on their risk for T2ELs. The prevalence of incidence of T2ELs at 1 year postoperatively was the main effectiveness index, and the colorectal ischemia complication rate was the main safety index.

Results:

A total of 431 patients were included in this clinical study. The endovascular aneurysm repair group and SP group comprised 383 patients and 48 patients, respectively. No statistically significant differences between these groups were observed. The HR group included 282 patients; 246 of these patients were in the HR endovascular aneurysm repair group, and 36 were in the HR SP group. The prevalence of incidence of T2ELs in the endovascular aneurysm repair group was higher than that of the SP group at 6 and 12 months postoperatively (15.4% vs 2.8% and 13.2% vs 0%); statistically significant differences between these groups were observed (p = 0.039 and p = 0.032). The postoperative follow-up period was 60 months. A Kaplan–Meier curve analysis indicated that the cumulative T2EL incidence rate of the endovascular aneurysm repair group was significantly higher than that of the SP group (p = 0.011). The LR group included a total of 149 patients; 137 of these patients were in the endovascular aneurysm repair group, and 12 were in the SP group. No statistically significant differences between these groups were observed.

Conclusions:

For patients with an abdominal aortic aneurysm who are at HR for T2ELs, SP could effectively, and safely prevent postoperative T2ELs.

Clinical Impact

This study points out that in patients with AAA, the sac prefilling technique is more suitable for patients with high-risk factors, so the operator should evaluate the patient’s anatomical condition more thoroughly before EVAR.

Keywords

AAA EVAR T2EL sac prefilling high risk

Get full access to this article

View all access options for this article.

References

Guirguis-Blake

Beil

Senger

, et al. Primary care screening for abdominal aortic aneurysm: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;322:2219–2238.

Ichihashi

Takahara

Fujimura

, et al. Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on aneurysm sac change: protocol of Clarify IMA study. BMJ Open. 2020;10:e031758.

Greenhalgh

Brown

Powell

, et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med. 2010;362:1863–1871.

Lederle

Freischlag

Kyriakides

, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA. 2009;302:1535–1542.

Gelfand

White

Wilson

SE.

Clinical significance of type II endoleak after endovascular repair of abdominal aortic aneurysm. Ann Vasc Surg. 2006;20:69–74.

Rehman

ZU.

Endoleaks: current concepts and treatments—a narrative review. J Pak Med Assoc. 2021;71:2224–2229.

Dijkstra

Zeebregts

Verhagen

HJM

, et al. Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data. J Vasc Surg. 2020;71:780–789.

Hou

Sac embolization and side branch embolization for preventing type II endoleaks after endovascular aneurysm repair: a meta-analysis. J Endovasc Ther. 2020;27:109–116.

Liu

Chen

Qin

, et al. A nomogram risk assessment model to predict the possibility of type II endoleak-related re-intervention after endovascular aneurysm repair (EVAR). Sci Rep. 2023;13:14.

10.

Bryce

Schiro

Cooper

, et al. Type II endoleaks: diagnosis and treatment algorithm. Cardiovasc Diagn Ther. 2018;8(suppl 1):S131–S137.

11.

Chaikof

Dalman

Eskandari

, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67:2–77.e2.

12.

Ultee

KHJ

Büttner

Huurman

, et al. Editor’s choice—systematic review and meta-analysis of the outcome of treatment for type II endoleak following endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2018;56:794–807.

13.

Biancari

Mäkelä

Juvonen

, et al. Is inferior mesenteric artery embolization indicated prior to endovascular repair of abdominal aortic aneurysm?. Eur J Vasc Endovasc Surg. 2015;50:671–674.

14.

Sidloff

Gokani

Stather

, et al. Type II endoleak: conservative management is a safe strategy. Eur J Vasc Endovasc Surg. 2014;48:391–399.

15.

Jones

Atkins

Brewster

, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1–8.

16.

van Marrewijk

Fransen

Laheij

, et al. Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up. Eur J Vasc Endovasc Surg. 2004;27:128–137.

17.

El Batti

Cochennec

Roudot-Thoraval

, et al. Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg. 2013;57:1291–1297.

18.

Deery

Ergul

Schermerhorn

, et al. Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair. J Vasc Surg. 2018;67:157–164.

19.

Walker

Tucker

Goodney

, et al. Type II endoleak with or without intervention after endovascular aortic aneurysm repair does not change aneurysm-related outcomes despite sac growth. J Vasc Surg. 2015;62:551–561.

20.

Kouvelos

Matsagkas

Spanos

, et al. Commentary: toward an EVAR prevention strategy for type II endoleak. J Endovasc Ther. 2017;24:573–574.

21.

Ogawa

Nishimaki

Fujiwara

, et al. A novel technique for the treatment of type 2 endoleak after endovascular aortic repair: sac embolization with balloon occlusion of the aorta (SEBOA). Cardiovasc Intervent Radiol. 2019;42:1488–1493.

22.

Nuckles

Nadal

Berger

, et al. Outcomes of type II endoleak treatment using ethylene vinyl alcohol copolymer (OnyxTM). Vasc Endovascular Surg. 2021;55:50–57.

23.

Fabre

Fadel

Brenot

, et al. Type II endoleak prevention with coil embolization during endovascular aneurysm repair in high-risk patients. J Vasc Surg. 2015;62:1–7.

24.

Mascoli

Freyrie

Gargiulo

, et al. Selective intra-procedural AAA sac embolization during EVAR reduces the rate of type II endoleak. Eur J Vasc Endovasc Surg. 2016;51:632–639.

25.

Dosluoglu

Rivero

Khan

, et al. Pre-emptive nonselective perigraft aortic sac embolization with coils to prevent type II endoleak after endovascular aneurysm repair. J Vasc Surg. 2019;69:1736–1746.

26.

Jouhannet

Alsac

Julia

, et al. Reinterventions for type 2 endoleaks with enlargement of the aneurismal sac after endovascular treatment of abdominal aortic aneurysms. Ann Vasc Surg. 2014;28:192–200.

27.

Aziz

Menias

Sanchez

, et al. Outcomes of percutaneous endovascular intervention for type II endoleak with aneurysm expansion. J Vasc Surg. 2012;55:1263–1267.

28.

Sarac

Gibbons

Vargas

, et al. Long-term follow-up of type II endoleak embolization reveals the need for close surveillance. J Vasc Surg. 2012;55:33–40.